TCL Archive Also in this 8-page issue: NCI advisors approve $15-million set-aside for laboratory testing on “reduced harm” tobacco products. July 9, 2004
TCL Archive FDA Advisors Ok Marketing Of Taxotere As Treatment For Advanced Breast Cancer October 20, 1995
TCL Archive Opdivo Study Shows 41 Percent One-Year Survival In Patients With at Least Two Past Therapies November 28, 2014
TCL Archive Double Trouble For NIH: Democrats Offer Small Increases, Bush May Veto The Bill. July 6, 2007
